Under the threat of tariffs, European stocks rose instead of falling. Strategists: A pullback in pharmaceutical stocks may be a good entry opportunity

European stock markets opened higher on Thursday, with investors reacting calmly to Trump's threat to impose tariffs on patented drugs, as the Stoxx 600 index rose by 0.3%. The healthcare sector fell by 0.2%, with Novo Nordisk and Zealand Pharma dropping by 1.7% and 2.2%, respectively. Strategist Sophie Huai believes this is a good opportunity to increase holdings in European stocks, despite the tension in the pharmaceutical industry. The market is focused on the Federal Reserve's inflation indicators to seek clues about the state of the U.S. economy